Alopecia associated with the use of semaglutide and tirzepatide: A disproportionality analysis using the FDA adverse event reporting system (FAERS) from 2022 to 2023

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Hannah Godfrey, Zachary Leibovit‐Reiben, Patrick Jedlowski, Rebecca Thiede
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Journal of the European Academy of Dermatology and Venereology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet